Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes

Bernhard Holzmann, Eva B. Bröcker, JüRgen M. Lehmann, Dirk J. Ruiter, Clemens Sorg, Gert Riethmüller, Judith P. Johnson

Research output: Contribution to journalArticlepeer-review

159 Scopus citations

Abstract

The antigenic profile of melanocytic cells in the course of local and systemic tumor progression of human malignant melanoma was investigated by the reactivity of a panel of monoclonal antibodies (MAbs) in frozen sections of histologically defined melanocytic lesions. Specific antigenic phenotypes made it possible to distinguish 5 groups of lesions which could be ranked in relation to each other due to the sequential acquisition or loss of progression markers. On this basis, a scheme of antigenic changes which accompany the stepwise transformation of normal skin melanocytes into highly malignant metastatic melanoma cells is proposed. The steps of tumor progression identified solely by phenotyping with MAbs were in complete concordance with the concept of melanoma progression derived from histological, statistical and clinical analyses. Furthermore, our finding that the expression of gp89 as well as HLA‐DR antigens can be induced by interferon‐γ in vitro provides evidence that immune interferon may play a role in the regulation of genes leading to phenotypic changes in progressing melanoma cells.

Original languageEnglish
Pages (from-to)466-471
Number of pages6
JournalInternational Journal of Cancer
Volume39
Issue number4
DOIs
StatePublished - 15 Apr 1987
Externally publishedYes

Fingerprint

Dive into the research topics of 'Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes'. Together they form a unique fingerprint.

Cite this